What is a Geniculate Ganglion Haemangioma
Geniculate ganglion haemangiomas (GGHs) are rare vascular lesions that arise in the vicinity of the geniculate ganglion (GG) of the facial nerve. These tumours typically cause facial nerve paralysis. These lesions account for merely 0.7% of all intratemporal vascular tumours diagnosed in clinical settings. Although commonly labelled as haemangioma, it is crucial to differentiate them from classic infantile hemangiomas, as GGHs possess distinct histological and clinical characteristics that warrant closer examination.
The Nature of Geniculate Ganglion Haemangiomas
Histologically, GGHs are characterised by irregularly dilated blood vessels that lack an internal elastic lamina and are devoid of associated smooth muscle. Furthermore, they lack typical immunohistochemical markers such as GLUT1 and Lewis Y, which are often present in true haemangioma. Due to their origin from the rich vascular network surrounding the GG, with the blood supply primarily derived from the petrosal artery, these lesions are considered vascular malformations rather than neoplasms.
Clinical Presentation
Patients with GGHs typically present with facial nerve dysfunction, including paresis, paralysis, or twitching. It is often wrongly interpreted as Bell’s Palsy. common Notably, the severity of the facial nerve dysfunction often surpasses the size of the lesion, leading to what is termed “vascular steal” or relative ischaemia of the nerve. In fact, progressive facial weakness was the most common symptom in clinical reviews, indicating that patients frequently experience moderate to severe dysfunction (House-Brackmann grades III to VI). Another common condition causing progressive facial nerve parlysis, fluctuating facial nerve paresis and the inability to recover in 6 months is facial nerve schwannoma. A significant correlation exists between GGHs and sensorineural hearing loss, sometimes observed as the first clinical sign, often stemming from cochlear damage or the formation of a cochlear fistula.
Diagnostic Imaging Techniques
The imaging modality of choice for diagnosing GGHs is magnetic resonance imaging (MRI), which exhibits hyperintensity on T2-weighted sequences, providing crucial information about the nature and extent of the lesion. Sometimes, the lesions may appear as heterogeneous contrast-enhancing tumours on T1-weighted images, with punctate areas of nonenhancement indicative of ossified regions. Given that 80% of GGHs measure less than 1 cm, they can easily be overlooked, necessitating a high index of suspicion when patients present with facial nerve paralysis.
High-resolution computed tomography (CT) can also play a vital role in confirming the diagnosis, particularly in identifying irregular borders and intralesional calcifications. Clinicians and radiologists must be vigilant, as subtle cochlear fistulas resulting from GGHs can be easily missed, complicating a patient’s clinical picture.
Electrophysiological Findings
Electromyography (EMG) findings in patients with GGHs reveal increased latency and characteristic patterns indicative of mixed denervation and regeneration. Specifically, clinicians may observe fibrillation potentials and polyphasic action potentials, reflecting ongoing nerve injury. This dys-synchrony among regenerating axons underscores the complexity of interpreting facial nerve function in the presence of these vascular malformations.
Treatment Options
The management of GGHs has evolved, with many specialists advocating for a more conservative approach aimed at preserving facial nerve integrity. Traditionally, resection was performed only after severe facial nerve paralysis ensued, often involving the sacrifice of the nerve and subsequent grafting. However, new techniques emphasise complete removal of the GGH while preserving the facial nerve. A study highlighted that patients undergoing a middle fossa approach for GGH excision—with successful preservation of the facial nerve—exhibited substantially better functional outcomes compared to those who underwent nerve resection and grafting.
In cases where hearing is intact, surgical intervention can be deferred, allowing for the lesion to be monitored. If facial paralysis progresses to House-Brackmann grade III or worse, surgical resection using a middle cranial fossa approach is recommended, ensuring that hearing preservation is prioritised based on the patient’s initial functional status.